Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VRT vs MRNA✓SelectedUSD · MRNAVRT vs MRNA performance historyLatest closeAs of-10.14%11/20
Stock and ETF performance explorer

VRT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,609.3%
MRNA return
+786.4%
Excess return
+822.9%
Maximum drawdown
-71.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.1%-2.2%-8.0%-10.0%
7D-17.7%-12.7%-5.0%-17.2%
30D-21.6%-20.7%-1.0%-20.9%
3M-37.2%+46.3%-83.4%-38.3%
6M-47.3%+305.2%-352.6%-53.5%
YTD+2.7%+561.2%-558.6%-14.0%
1Y+4.3%+772.1%-767.8%-15.0%
3Y+274.6%+147.0%+127.6%+230.1%
5Y+519.3%-26.1%+545.3%+466.0%
All+1,609.3%+786.4%+822.9%+1,718.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling